Dataset from A Phase IV, Multi-center, Open-label Study to Assess Clinical Recurrence Related to Compliance With Treatment With MMX Mesalamine 2.4g/Day Given Once Daily for the Maintenance of Quiescent Ulcerative Colitis (UC)
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00007260
下载链接
链接失效反馈官方服务：
资源简介：
To evaluate the percentage of subjects with clinical recurrence of UC at 6 months using MMX
mesalamine once daily.
创建时间：
2024-11-26
